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Abstract 
In this paper changes in the quality of health adjusted life expectancy of the British 
population between 1991 and 1998 are analyzed. It is found that at all given age 
levels life expectancy increased during this period. Life expectancy at birth increased 
by 1 year for women and by 1.5 years for men. It is further found that the prevalence 
of health problems and handicaps has increased during the 1990s. For all age 
categories distinguished the self-assessment of the quality of health also declined, on 
average. We finally find that quality adjusted life expectancy declined between 1991 
and 1998 rather than increased. 
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HEALTH-ADJUSTED LIFE EXPECTANCY IN BRITAIN, 1991-1998 
 
Keywords: health, life expectancy 
 
Abstract 
In this paper changes in the quality of health adjusted life expectancy of the British 
population between 1991 and 1998 are analyzed. It is found that at all given age 
levels life expectancy increased during this period. Life expectancy at birth increased 
by 1 year for women and by 1.5 years for men. It is further found that the prevalence 
of health problems and handicaps has increased during the 1990s. For all age 
categories distinguished the self-assessment of the quality of health also declined, on 
average. We finally find that quality adjusted life expectancy declined between 1991 
and 1998 rather than increased. 
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1. Introduction 
 
Like in many other western countries health care expenditures in Britain have risen 
substantially over the past decade. Between 1991 and 1999 expenditures on the 
National Health Service increased by 0.6 – 6.7% annually, while expenditures per 
capita increased by £4.35 – 42.91 annually. In 1991 health care expenditures per 
capita amounted to £688.22, by 1998 this had increased to £829.30.  
In 2002, the British government announced a plan for even further increases in 
health care expenditures. It is planned that health care expenditures will increase by 
7.4% annually in real terms between 2002-03 and 2007-08. Over this period 
expenditure on the National Health Service is planned to rise by 44% in real terms. 
The extra investment will increase health expenditure from 7.7% to 9.4% of gross 
domestic product in 2008 (Moore 2002). 
 An obvious question to ask is whether these expenditure increases really 
improve the health of the population? It is by no means obvious that higher health 
care expenditures lead to a better health. A classic example is Illich (1975), who 
claims that there is a negative causality: more health care leads to dependence, and 
this in turn leads to a decline in health. However, recent empirical studies suggest the 
opposite. For example, Rivera (2001) analyses the relation between public health 
expenditure and self-assessed health status. This study finds that higher per capita 
public health expenditures in a region are associated with better a physiological and 
physical health status. Using aggregate data, Berger & Messer (2002) basically 
confirm the cross-section data findings by Rivera (2001). Berger & Messer (2002) 
find that higher health care expenditures are associated with lower mortality rates. 
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However, this study also finds that countries where a larger share of health care 
expenditures is publicly financed have higher mortality rates. 
It is difficult to prove that there is a direct causal relation between health care 
expenditure and the health status of the population. Health care expenditure also 
need not be the most important factor. Even if expenditures are high, barriers to 
access may be an impediment to health for all. However, the question can be asked 
whether during a period in which health care expenditures increased year by year, 
the health status of the population increased as well? In this paper we therefore 
analyze whether the health state of the British population has improved in the 1990s.  
 
There is a small literature on the evolution of health in western countries during the 
past twenty years. This literature does not unequivocally show that the health of the 
population has improved over time.  
Burström, Johannesson & Diderichsen (2003) compute the value of the 
change in health in Sweden between 1980 and 1997. This study finds that in this 
period life expectancy for infants in Sweden increased by 3.68 years for males and 
2.70 years for females. Among older age groups av rage health status increased. 
However, among younger age groups average health status decreased. Expected 
quality-adjusted life years for infants increased by 2.64 years for males and 0.54 
years for females. This study concludes that older persons in Sweden have 
experienced considerable health gains whereas the health gains have been small or 
non-existent for younger women. 
Cutler & Richardson (1997, 1998) use ordered probit regressions to estimate 
the changes in the value of health capital in the United States between 1970 and 
1990. This study finds that during this period quality-adjusted life years increased by 
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as much as 30%. This increase is to a large extent due to a decline in mortality rates. 
Using a 3% discount rate, health improved most for the elderly and least for children. 
The rate of female to male health was relatively constant over this period. At birth 
women and men have nearly equal health, while at age 65 women have more health 
capital than men. 
 
In this paper we use the concept of health-adjusted life expectancy (HALE) as a 
summary measure to analyze the changes in the quality of health-adjusted life 
expectancy in Britain in the 1990s.1 HALE is a summary measure of population 
health. HALE estimates the average time in years that a person at a given age can 
expect to live in the equivalent of full health. The morbidity or quality of life 
component of HALEs is referred to as health-related quality of life (HRQL) or quality-
adjusted life years weights (QALY weights). These QALY weights are combined with 
tables on life expectancy to create HALEs (for a review of the measures referred to 
here and others, see Gold, Stevenson & Fryback 2002). Changes in HALE can be 
decomposed into three factors: a change in life expectancy, changes in the 
prevalence of diseases at any given age, and the health state conditional on the 
prevalence of diseases and handicaps. As people live to an older age, the first factor 
contributes positively to the HALE. However, the increase in life expectancy is partly 
because the chances of surviving a serious illness are greater now than in the past. 
As a result the increase in life expectancy is partly due to an increase in life years 
lived in less than perfect health. Consequently, the prevalence of (chronic) diseases 
has increased. So the second factor is likely to contribute negatively to HALE. Finally, 
we may expect that health conditional on having survived a serious illness has 
 
1 See Rosenberg, Fryback & Lawrence (1999) for an alternative method to calculate health 
adjusted life expectancy. 
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improved due to improved medical care. So, the first and the third factor are likely to 
increase HALE, while the second reduces it. The net effect is therefore ambiguous. 
 In the remainder of this paper we will present empirical data on the factors that 
contribute to HALE, i.e. we will analyze the evolution of life expectancy, the 
prevalence of diseases and handicaps and the (subjective evaluation) of the 
individual’s health condition over the period 1991-1998. Data on the prevalence of 
diseases and handicaps and the self-assessments of the health status are combined 
to produce QALY weights. These QALY weights are used to calculate HALE by 
multiplying them by the figures on life expectancy. 
 
2. The health capital model 
 
In the empirical modeling of the quality of health three concepts are distinguished. 
The first is the true quality of health H*. The true quality of health is a latent variable 
that can not be observed directly. What we observe are an objective measure of the 
health status of the individual, denoted by Ho, and a subjective measure of the quality 
of health, Hs. The objective health measure refers to the prevalence of a number of 
illnesses and handicaps among the respondents in our sample and their functional 
ability. Ho refers to a vector of dummy variables on illnesses and handicaps. The 
subjective measure of health, Hs, is measured by the response to the survey 
question: “Compared to people of your own age, would you say your health has on 
the whole been: 1) excellent, 2) good, 3) fair, 4) poor or 5) very poor?”.  
 
We assume that the latent quality of health variable is determined by the prevalence 
of diseases and handicaps and other individual characteristics: 
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6
X is a vector of individual characteristics, S are vectors of coefficients and T is a 
standard normal distributed random term capturing unmeasured and unmeasurable 
effects on the true health status. The vector X includes variables for years of 
education, age, marital status, number of dependent children and country of birth. 
 
The observed health status Hs is a categorical ordered response variable. The 
observed health variable is assumed to be related to the latent variable in the 
following way: 
 
where n is the number of response categories (i.e. n ranges from 1 to 5 for our 
subjective health measure) and Ui are threshold levels that demarcate the different 
response categories. We further assume that U0 = -  en Un = . This specification is 
know in the literature as the ordered probit model (McKelvey & Zavoina 1975).  
 
We follow Cutler & Richardson (1997, 1998) in calculating QALY weights from the 
estimates of the S1 coefficients. Let S0 + Ho1 + X2 represent the impact of health 
problems, handicaps and other individual characteristics on health.  As S0 + Ho1 +
X2 is not scaled and can range from - to , the representation of the impact of 
 +X+H+=H o0
*
21
n0,....,=i,H<i=H i*1-is  
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health problems needs to be normalized to produce a QALY weight. Following Cutler 
& Richardson (1997, 1998) we normalize by dividing them by the difference between 
the borderline between excellent health and that of a very poor health. It is thereby 
assumed that an excellent health corresponds to a near perfect health and a very 
poor health corresponds to near death. The individual QALY weights are defined as: 
 
The mean values of the QALY weights are taken as the quality of the health of the 
population.  
 
The final step is to calculate the quality of health adjusted life expectancy (HALE). 
The HALE are calculated by multiplying the QALY weight by the age specific 
remaining life expectancy. 
 
3. The data for calculating the quality of health 
 
The data for calculating the QALY weights are taken from the 1991 and 1998 waves 
of the British Household Panel Survey (BHPS 1995). The BHPS - carried out by the 
Institute of Social and Economic Research at the University of Essex - is an annual 
longitudinal survey of each adult member of a nationally representative sample of 
more than 5,000 households (approximately 10,000 individuals) in Great Britain. The 
1 2
o
10
4 1
+ + X -H=QALYWEIGHT
 - 
   
 
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same individuals are interviewed in successive waves. If they leave the household all 
adult members of their new household are also interviewed. Details about this survey 
can be found in Taylor (1992). The sample includes all individuals aged 15 and older. 
After eliminating a small number of observations with missing values on the self-
reported health status and on the health condition variables, 5416 observations on 
females in 1991 and 5848 in 1998 could be used in the analyses. For males we have 
4815 observations in 1991 and 5048 in 1998. 
 
As was already mentioned, the subjective health measure Hs is defined by the 
response to the survey question “Compared to people of your own age, would you 
say that your health has on the whole been: 1) excellent, 2) good, 3) fair, 4) poor or 
5) very poor?”. According to Fayers & Sprangers (2002), “There is widespread 
agreement that this simple global question provides a useful summary of how 
patients perceive their overall health status. This view is also borne out by the large 
number of studies that have consistently shown, in a wide range of disease areas, 
that SRH [Self-Reported Health] is a powerful predictor of clinical outcome and 
mortality.” One advantage of using self-assessments of health for calculating QALY 
weights is that the cognitive burden on respondents is lower than with other 
techniques, such as the standard gamble and the time trade-off methods.  In Fryback 
et al. (1993) it is shown that the scores on this self-assessed overall quality of health 
correlate highly with the scores of other quality of life indicators that are frequently 
used in QALY analysis, such as the time trade-off assessment, the quality of well-
being index and the outcomes of a general health perception questionnaire. 
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For the objective health measure Ho the response to the following survey question is 
used: “Do you have any of the health problems or disabilities listed on this card? 
(exclude temporary conditions)”. Respondents are shown a card with a list of 
conditions:  
- Problems or disability connected with: arms, legs, hands, feet, back, or 
neck (including arthritis and rheumatism);  
- Difficulty in seeing (other than needing glasses to read normal size print);  
- Difficulty in hearing;   
- Skin conditions/allergies;  
- Chest/breathing problems, asthma, bronchitis;  
- Heart/blood pressure or blood circulation problems;  
- Stomach/liver/kidneys or digestive problems;  
- Diabetes;  
- Anxiety, depression or bad nerves;  
- Alcohol or drug related problems;  
- Epilepsy;  
- Migraine or frequent headaches;  
- Other health problems. 
The categorization of the health problems and disabilities on this list is fairly broad. 
For example, heart and blood pressure problems includes people with high blood 
pressure and patients with severe cardiovascular diseases. A more detailed 
classification of health problems and disabilities would, however, have required a 
much larger sample size in order to obtain sufficiently large cell sizes. 
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4. Estimation results 
 
In this section we discuss the changes of mortality and morbidity over the period 
1991-1998 for men and women. We also present the results of the ordered probit 
estimates of subjective health. These probit estimates are used to calculate gender 
and age group specific QALY weights. 
 
Life expectancy 
Table 1 contains the life expectancy – at birth and conditional on attaining a certain 
age - for men and women in 1991 and 1998. For men life expectancy at birth 
increased by 1.5 years from 73.2 years in 1991 to 74.7 years in 1998. For women it 
increased by 1 year, from 78.7 to 79.7 years. If we look at the increases in life 
expectancy for different age groups, we see that at all age levels the conditional life 
expectancy increased. The largest increase in life expectancy occurred for men at 
age 20 and 30: for these age groups the conditional life expectancy increased by 1.4 
years. Among women we find that for all  ages between 5 and 60 the conditional life 
expectancy increased by 0.7 to 0.9 years. 
 
Table 1 around here 
 
Self-assessed quality of health 
The figures on life expectancy show a notable increase. However, if we look at the 
quality of health a somewhat different picture emerges. In table 2 and 3 the 
frequency distribution of the self-assessed health status for men and women in 1991 
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and 1998 are presented. In order to make the figures on self-assessed health as 
comparable as possible with the figures on life expectancy, we present figures by five 
age groups. 
 If we look at the distribution of health for all age groups combined, we find that 
for both men and women self-assessed health has deteriorated between 1991 and 
1998. In 1991 nearly 32% of the men in the sample evaluated their health as 
‘excellent’, while another 44.5% rated it as ‘good’. Less than 7% of the men in 1991 
rated their health as ‘(very) poor’. By 1998 the share of men in excellent or good 
health had declined and the number of men in (very) poor health had gone up. In 
1998 less than 25% of the men rated their health as excellent and 46.6% said to be 
in good health. The share of men in (very) poor health had increased to 9.7%. A 
similar trend can be observed among women. The percentage of women in excellent 
health declined from 25.7% in 1991 to 19.0% in 1998, while the percentage of 
women in (very) poor health increased from 9.6% to 11.7%. 
 
Tables 2 and 3 around here 
 
One potential explanation for the deterioration of health is the increase in life 
expectancy. If this increase is mainly caused by in increase life years spent in less 
than perfect health, we may expect the subjective evaluation to deteriorate over time. 
We would then expect that the evaluation of health status within age groups to 
remain constant. This is not what the figures in table 2 and 3 show, however. Both 
among men and among women we find that in all of the six age groups distinguished 
the share of people in excellent health declined between 1991 and 1998, while the 
share of people in (very) poor health increased. 
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An alternative explanation for the deterioration of the self-assessment of health is that 
people have become more pessimistic about their own health. I.e. they evaluate the 
same objective health state more negatively in 1998 than in 1991. Whether this 
explanation holds can be seen if we compare the self-assessments with the 
prevalence of health problems and disabilities in 1991 and 1998. 
 
The prevalence of health problems and disabilities 
Table 4 contains the prevalence of health problems and disabilities among men in 
1991 and 1998. Similar figures for women are found in table 5. The trends in the 
prevalence of these health impairments are remarkably similar for men and women. 
For both men and women we find an increase in the prevalence of problems with 
arms, legs, etc, difficulty in hearing, skin conditions and allergies, heart and blood 
pressure circulation problems, stomach, liver and kidney problems, diabetes, nerves 
and anxiety problems and depression. One example is the increase in the prevalence 
of diabetes among men. The prevalence of diabetes among men increased from 
1.9% to 2.9% in 1998. Also in all age groups the prevalence increased. Among men 
aged 25-40, for example, it doubled from 0.6% to 1.2%. 
 
Tables 4 and 5 around here 
 
Only difficulty in seeing is less frequently reported in 1998 than in 1991. On a few 
health impairments the trends differ between men and women. Among men the 
prevalence of chest and breathing problems declined, while this increased among 
women. Alcohol and drug use increased slightly among men, but remained constant 
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among women. Epilepsy increased somewhat among women but remained constant 
among men. Finally, migraine and chronic headaches declined among men but 
increased among women. The overall picture that emerges is that both among men 
and among women the prevalence of health problems and disabilities has increased 
between 1991 and 1998. This contradicts the idea that the deterioration of the self-
assessed health status in table 2 and 3 is merely because people have become more 
pessimistic and have changed the interpretation they attach to notions like ‘excellent’ 
and ‘poor’ health. It suggests that the negative change in self-assessed quality of 
health reflects a deterioration of the true health status. 
 As expected, the prevalence of health problems and disabilities is higher 
among older age groups than among the younger ones. However, if we look within 
age groups, we see similar trends as for the sample as a whole. For most age groups 
health problems and disabilities the prevalence increased between 1991 and 1998. 
Only for a few age groups the prevalence decreased over the period 1991-1998. 
 
Ordered probit estimates of self-assessed quality of health 
The ordered probit estimates are used to calculate Quality of Life weights. The 
estimation results of the probit equations on self-assessed health status for men and 
women are found in table 6 and 7, respectively. Health problems and disabilities 
generally lower the self-reported health status.  Especially, problems connected with 
arms, legs, hands, feet, back, or neck,  chest and breathing problems such as 
asthma and bronchitis, heart problems and blood pressure or blood circulation 
problems, stomach, liver, kidneys or digestive problems, diabetes, problems caused 
by anxiety, depression or bad nerves and epileptic problems have strong negative 
effects on the self-assessment of the health status.  
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Tables 6 and 7 around here 
 
We further find that years of education generally has a positive, and among men in 
particular, a statistically significant effect on self-assessed health. In most of the 
equations age has a positive effect on health as well. This is surprising as one might 
expect health to decline with age. Two explanations can be given for this unexpected 
finding. First, the age effect is conditional on the prevalence of health problems and 
handicaps. Secondly, the subjective health state question explicitly asks respondents 
about their health “compared to people of your own age”. This introduces a source of 
age norming in the respondents’ answers which causes the reverse sign of the age 
effect on health in the estimations (see Groot 2000). 
 
QALY weights 
The probit estimates are used to calculate QALY weights. Table 8 contains the 
average QALY weights by age group for men and women. Three conclusions can be 
drawn from the results in this table. First, we find – as expected - that the QALY 
weights are lower for older age groups than for younger ones. For example, in 1991 
the average QALY weight for men aged 25 or younger is 0.889, while for men aged 
75 and older it is 0.663. For both men and women we find for both years that the 
average QALY weight of an older age group is always lower than that of a younger 
one. 
 
Table 8 around here 
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Secondly, we find that the average QALY weights for women are always less than 
the corresponding average QALY weights for men. This reflects the lower health 
status and the higher prevalence of health problems and disabilities among women. 
 Finally, we find that for both men and women and for all age groups the 
average QALY weight in 1998 is lower than the average QALY weight in 1991. This 
corresponds to the lower self-rating of health and the higher prevalence of health 
problems and disabilities in 1998 compared to 1991. 
 
HALE 
Finally, we calculate the quality of health adjusted life expectancy (HALE). This is 
done by multiplying the life expectancy figures in table 1 with the age group specific 
QALY weights in table 8. An example illustrates how the HALE is calculated. The life 
expectancy at birth of men in 1991 is 73.2 years. Of these, 25 years are spent with 
an average QALY weight of 0.889. The next 15 years are spent with QALY weight 
0.858, and so on. Finally, the last years of the life expectancy are spent in average 
QALY weight of 0.670.   
 The quality of health adjusted life expectancies are found in table 9. As might 
be expected - based on the differences in self-assessed health, the prevalence of 
health problems and disabilities and the QALY weights - the differences between 
men and women in quality adjusted life expectancy are less than the male-female 
differences in life expectancy that were found in table 1. We find that below the age 
of 30, quality adjusted life expectancy of men actually exceeds the quality adjusted 
life expectancy of women. After the age of 30 we find that women have a longer 
quality adjusted life expectancy. 
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A second conclusion that can be drawn is that quality adjusted life expectancy 
has declined between 1991 and 1998 rather than increased. The increase in life 
expectancy in the 1990s has been more than off-set by a decline in quality of life. 
 
Table 9 around here 
 
5. Conclusion 
 
In this paper we have used quality of health adjusted life expectancy (HALE) as a 
summary measure for health. We have used the HALE to calculate the changes in 
health of the British population in the 1990s. The most notable finding is that quality 
of health adjusted life expectancy has declined rather than increased in the 1990s. 
 This finding contradicts some of the findings in the influential Wanless report 
‘Securing good health for the whole population’ (Wanless 2003). In this report it is 
stated that: “In the UK healthy life expectancy at birth is increasing. In 1999, the 
number of years males could expect to live in good or fairly good health was 66.6 
years, compared to 64.4 years in 1981. For females, the equivalent figures were 68.9 
and 66.7 years” (Wanless 2003, p. 19). However, the Wanless report also notes that 
the prevalence of all major disease groups – including musculoskeletal disorder, 
heart and circulatory disease and respiratory disease – increased between 1994 and 
1998 (Wanless 2003, p. 21-22). Also the prevalence of Type2 diabetes is increasing. 
It is even noted that the most deprived fifth of the population have a 50 percent 
increased risk of Type 2 diabetes (Wanless 2003, p. 22). 
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A major reason for the decline in HALE is that - for both men and women - the self-
assessed health status has declined and the prevalence of diseases and handicaps 
has increased for all age groups distinguished. A natural question to ask is how 
reliable these figures on self-assessed health are? Our data do not allow us to test 
the reliability of the self-assessment of health, other than that we find that the 
prevalence of health problems and disabilities are good predictors of the self-
assessment. Crossley & Kennedy (2002) analyze the reliability of self-assessed 
health status using Australian data in which a random sub-sample of respondents 
answer a standard self-assessed health question twice – before and after an 
additional set of health related questions. This study finds that 28% of the 
respondents change their response: 13.6% report a higher level of health whilst 
14.8% report a lower level of health after a general health and well-being 
questionnaire is answered. As about the same number of respondents change their 
self-assessment upwards as downwards, the null-hypotheses that the means of both 
distributions are the same can not be rejected. They do find, however, that the null 
hypotheses that the distributions are the same is strongly rejected. We conclude from 
this that at least the means of the distribution provide reliable information about the 
health status of the sample as a whole. In our study we find that for all gender and 
age groups, the means of the self-assessed health state declined between 1991 and 
1998. 
 
Another potential point of criticism concerns the fact that respondents are asked to 
evaluate their health relative to others with the same age (“Compared to people of 
your own age, would you say your health has on the whole been….”). It is possible 
that because of some exogenous change – for example a dramatic improvement of 
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medical technology – the health status of the whole population increases uniformly. 
By asking people to compare their own age with that of others, a uniform increase in 
health status may leave the relative distribution unchanged (some people still 
consider themselves being in poor health compared to other although their health 
status has improved). 
 We consider the source of bias to be only minor. First, we compare the health 
status of the people over a relatively short period of time. It is unlikely that dramatic 
improvements in medical technology have occurred that have affected the health of 
the entire population. Secondly, one may expect such uniform change to be in the 
direction of a general health improvement, not in a deterioration of the health status. 
Our findings show a decline in subjective health. Thirdly, people are asked to 
compare their health with that of people their own age. One way to eliminate this 
source of bias is to compare the changes in health status over time for similar age 
groups. We find that in all age groups, self reported health has declined. Finally, as 
has been noted before, we do not only find that the self-assessment of the health 
status has deteriorated, the prevalence of diseases and handicaps has increased as 
well. 
 
Finally, we may ask why self-assessed health has deteriorated and why the 
prevalence of most health problems and handicaps has increased in the 1990s? 
Three possible explanations suggest itself. First, as was already noted before, the 
increase in life expectancy is for a large part an increase in life expectancy in less 
than perfect health. This means an increase in the prevalence of chronic diseases in 
the population. A second explanation is that – because of  improved medical 
technology and a greater awareness of the risks of health problems among the 
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population – diseases are nowadays diagnosed sooner and better than before. A 
final explanation is that the life style of the population has become less healthy – i.e. 
an increase in alcohol consumption and obesity – which has led to an increase in 
(chronic) diseases. 
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Table 1 Life expectancy in years in Britain 1991-1998, by gender and age 
 At age At birth 
5 20 30 50 60 70 80 
Men 
1991 73.2 68.9 54.2 44.7 26.0 17.7 11.1 6.4 
1998 74.7 70.3 55.6 46.1 27.4 18.9 11.9 6.7 
Women 
1991 78.7 74.3 59.5 49.7 30.6 21.9 14.3 8.2 
1998 79.7 75.2 60.3 50.5 31.4 22.6 14.7 8.4 
Source: National Statistics Britain 
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Table 2 Frequency distribution subjective health status 1991-1998, men by age 
group 
 All Age group 
25 or 
younger 
25 - 40 40 - 55 55 - 65 65 - 75 Older 
than 75 
1991 
Very poor 1.9% 0.5% 1.2% 1.9% 3.0% 3.6% 5.5% 
Poor 5.1% 2.5% 2.5% 5.7% 8.7% 9.7% 10.2% 
Fair 16.7% 15.3% 13.2% 15.4% 19.6% 28.1% 20.8% 
Good 44.5% 44.5% 48.0% 44.0% 41.8% 39.3% 42.4% 
Excellent 31.8% 37.2% 35.1% 33.1% 26.9% 19.2% 21.2% 
#observations 4832 915 1453 1183 572 473 236 
1998 
Very poor 2.4% 0.4% 1.0% 3.2% 3.5% 4.9% 5.2% 
Poor 7.3% 4.5% 5.1% 7.6% 11.3% 9.7% 15.1% 
Fair 19.0% 16.1% 16.3% 15.8% 24.6% 29.4% 27.1% 
Good 46.6% 51.1% 48.2% 47.1% 41.5% 41.4% 40.9% 
Excellent 24.7% 27.8% 29.4% 26.2% 19.0% 14.6% 11.7% 
#observations 5050 898 1546 1244 564 507 291 
Page 24 of 37
Editorial Office, Dept of Economics, Warwick University, Coventry CV4 7AL, UK
Submitted Manuscript
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
24
Table 3 Frequency distribution subjective health status 1991-1998, women by 
age group 
 All Age group 
25 or 
younger 
25 - 40 40 - 55 55 - 65 65 – 75 Older 
than 75 
1991 
Very poor 2.3% 0.6% 1.2% 1.8% 4.1% 4.8% 5.6% 
Poor 7.3% 5.1% 5.5% 8.3% 5.5% 11.1% 12.6% 
Fair 19.3% 18.8% 15.0% 17.2% 22.5% 25.7% 28.6% 
Good 45.4% 47.1% 47.0% 45.0% 46.5% 42.6% 39.6% 
Excellent 25.7% 28.4% 31.4% 27.7% 21.5% 15.7% 13.6% 
#observations 5424 887 1565 1300 641 619 412 
1998 
Very poor 3.0% 1.1% 2.0% 2.9% 3.3% 4.4% 8.2% 
Poor 8.7% 6.3% 6.7% 8.4% 9.7% 12.2% 15.1% 
Fair 22.3% 16.9% 18.4% 22.2% 26.1% 28.6% 33.0% 
Good 47.0% 52.8% 49.0% 47.6% 45.2% 43.8% 34.3% 
Excellent 19.0% 23.0% 23.9% 18.9% 15.6% 11.0% 9.4% 
#observations 5848 944 1743 1392 639 608 522 
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Table 4 Prevalence of health problems and disabilities 1991-1998, men 
 All Age 
 25 25 - 40 40 - 55 55 - 65 65 - 75 75 > 
1991 
Problems with 
arms, legs, etc. 
0.208 0.081 0.140 0.223 0.345 0.362 0.394 
Difficulty in 
seeing 
0.068 0.049 0.036 0.068 0.081 0.108 0.216 
Difficulty in 
hearing 
0.088 0.022 0.034 0.075 0.138 0.210 0.377 
Skin conditions, 
allergies 
0.078 0.102 0.087 0.065 0.053 0.072 0.068 
Chest, breathing 
problems 
0.105 0.109 0.089 0.065 0.117 0.197 0.170 
Heart, blood 0.108 0.009 0.030 0.105 0.224 0.320 0.275 
Stomach, liver, 
kidney 
0.053 0.020 0.043 0.051 0.089 0.110 0.055 
Diabetes 0.019 0.002 0.006 0.017 0.037 0.049 0.081 
Nerves, anxiety, 
depression 
0.033 0.014 0.028 0.035 0.047 0.055 0.047 
Alcohol, drugs 0.005 0.006 0.005 0.005 0.005 0.002 0.013 
Epilepsy 0.007 0.012 0.006 0.006 0.004 0.006 0.013 
Migraine, chronic 
headaches 
0.043 0.037 0.052 0.047 0.037 0.032 0.021 
Other 0.034 0.024 0.023 0.029 0.049 0.045 0.106 
1998 
Problems with 
arms, legs, etc. 
0.255 0.080 0.163 0.280 0.420 0.443 0.522 
Difficulty in 
seeing 
0.044 0.021 0.023 0.039 0.041 0.085 0.179 
Difficulty in 
hearing 
0.097 0.021 0.034 0.077 0.166 0.228 0.388 
Skin conditions, 
allergies 
0.100 0.101 0.117 0.091 0.088 0.098 0.065 
Chest, breathing 
problems 
0.131 0.109 0.106 0.097 0.164 0.224 0.241 
Heart, blood 0.135 0.006 0.034 0.118 0.295 0.396 0.375 
Stomach, liver, 
kidney 
0.066 0.015 0.047 0.089 0.086 0.112 0.117 
Diabetes 0.029 0.007 0.012 0.023 0.049 0.085 0.072 
Nerves, anxiety, 
depression 
0.050 0.023 0.049 0.057 0.071 0.053 0.055 
Alcohol, drugs 0.007 0.007 0.008 0.006 0.007 0.006 0.000 
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Epilepsy 0.007 0.009 0.012 0.002 0.007 0.002 0.007 
Migraine, chronic 
headaches 
0.047 0.033 0.056 0.053 0.032 0.053 0.031 
Other 0.042 0.021 0.023 0.046 0.062 0.079 0.093 
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Table 5 Prevalence of health problems and disabilities 1991-1998, women 
 All Age 
  25 25 - 40 40 - 55 55 - 65 65 - 75 75 > 
1991 
Problems with 
arms, legs, etc. 
0.249 0.083 0.102 0.274 0.395 0.459 0.542 
Difficulty in 
seeing 
0.078 0.046 0.035 0.062 0.080 0.137 0.264 
Difficulty in 
hearing 
0.067 0.026 0.021 0.038 0.081 0.141 0.283 
Skin conditions, 
allergies 
0.124 0.190 0.160 0.104 0.086 0.058 0.075 
Chest, breathing 
problems 
0.103 0.093 0.082 0.081 0.122 0.150 0.170 
Heart, blood 0.126 0.037 0.035 0.090 0.217 0.343 0.310 
Stomach, liver, 
kidney 
0.057 0.037 0.044 0.058 0.073 0.073 0.097 
Diabetes 0.016 0.003 0.004 0.012 0.038 0.029 0.046 
Nerves, anxiety, 
depression 
0.068 0.037 0.062 0.075 0.078 0.092 0.087 
Alcohol, drugs 0.003 0.002 0.006 0.002 0.003 0.000 0.002 
Epilepsy 0.007 0.012 0.005 0.009 0.006 0.002 0.000 
Migraine, chronic 
headaches 
0.109 0.118 0.127 0.131 0.105 0.061 0.029 
Other 0.065 0.042 0.043 0.078 0.075 0.092 0.099 
1998 
Problems with 
arms, legs, etc. 
0.313 0.086 0.169 0.301 0.518 0.591 0.661 
Difficulty in 
seeing 
0.055 0.015 0.024 0.028 0.075 0.095 0.232 
Difficulty in 
hearing 
0.074 0.028 0.025 0.047 0.075 0.158 0.293 
Skin conditions, 
allergies 
0.151 0.195 0.182 0.142 0.105 0.110 0.096 
Chest, breathing 
problems 
0.142 0.162 0.122 0.108 0.147 0.202 0.190 
Heart, blood 0.163 0.028 0.044 0.132 0.265 0.425 0.458 
Stomach, liver, 
kidney 
0.087 0.045 0.063 0.076 0.122 0.151 0.157 
Diabetes 0.026 0.009 0.009 0.019 0.041 0.074 0.061 
Nerves, anxiety, 
depression 
0.105 0.050 0.100 0.125 0.124 0.117 0.132 
Alcohol, drugs 0.003 0.005 0.002 0.005 0.002 0.002 0.000 
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Epilepsy 0.009 0.013 0.010 0.011 0.003 0.007 0.000 
Migraine, chronic 
headaches 
0.131 0.143 0.149 0.152 0.106 0.099 0.056 
Other 0.070 0.033 0.058 0.073 0.085 0.097 0.119 
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Table 6 Parameter estimates health status men, 1991-1998 (standard errors in 
brackets) 
 All Age 
  25 25 - 40 40 - 55 55 - 65 65 - 75 75 > 
1991 
Health problems and disabilities 
Problems with 
arms, legs, etc. 
-0.691 
(0.041)
-0.664 
(0.135)
-0.603 
(0.084)
-0.783 
(0.079)
-0.690 
(0.101)
-0.652 
(0.111)
-0.765 
(0.153)
Difficulty in 
seeing 
-0.396 
(0.064)
-0.058 
(0.173)
-0.177 
(0.159)
-0.366 
(0.129)
-0.528 
(0.170)
-0.607 
(0.165)
-0.590 
(0.190)
Difficulty in 
hearing 
-0.091 
(0.058)
-0.365 
(0.251)
-0.226 
(0.162)
-0.191 
(0.123)
-0.053 
(0.135)
0.158 
(0.127)
-0.207 
(0.155)
Skin conditions, 
allergies 
-0.045 
(0.060)
-0.065 
(0.123)
0.142 
(0.107)
-0.059 
(0.132)
-0.222 
(0.207)
-0.374 
(0.200)
-0.016 
(0.291)
Chest, breathing 
problems 
-0.795 
(0.052)
-0.816 
(0.121)
-0.703 
(0.102)
-0.857 
(0.132)
-0.830 
(0.150)
-1.044 
(0.135)
-0.832 
(0.196)
Heart, blood -0.726 
(0.054)
-1.474 
(0.395)
-0.544 
(0.172)
-0.904 
(0.106)
-0.791 
(0.115)
-0.886 
(0.116)
-0.265 
(0.164)
Stomach, liver, 
kidney 
-0.689 
(0.070)
-0.749 
(0.267)
-0.770 
(0.142)
-0.513 
(0.146)
-0.853 
(0.170)
-0.648 
(0.166)
-1.004 
(0.315)
Diabetes -0.914 
(0.114)
-0.897 
(0.795)
-1.354 
(0.391)
-1.011 
(0.245)
-1.001 
(0.250)
-1.014 
(0.240)
-0.561 
(0.265)
Nerves, anxiety, 
depression 
-0.882 
(0.088)
-1.002 
(0.317)
-1.150 
(0.177)
-0.734 
(0.173)
-1.039 
(0.222)
-0.568 
(0.230)
-0.903 
(0.338)
Alcohol, drugs -0.364 
(0.218)
1.563 
(0.629)
-1.246 
(0.411)
-0.707 
(0.450)
-0.629 
(0.644)
- -0.019 
(0.687)
Epilepsy -0.993 
(0.184)
-0.551 
(0.333)
-1.370 
(0.381)
-0.956 
(0.405)
-1.056 
(0.795)
-1.316 
(0.638)
-1.455 
(0.694)
Migraine, chronic 
headaches 
-0.241 
(0.078)
-0.052 
(0.195)
-0.320 
(0.132)
-0.240 
(0.152)
-0.299 
(0.247)
-0.479 
(0.297)
0.342 
(0.503)
Other -0.848 
(0.086)
-0.927 
(0.236)
-0.731 
(0.195)
-0.875 
(0.189)
-0.684 
(0.216)
-1.276 
(0.250)
-0.916 
(0.237)
Other control variables 
Years of 
education 
0.039 
(0.006)
0.015 
(0.024)
0.032 
(0.010)
0.040 
(0.011)
0.035 
(0.018)
0.057 
(0.016)
0.074 
(0.032)
Age 0.001 
(0.001)
0.041 
(0.015)
-0.012 
(0.007)
0.011 
(0.009)
0.025 
(0.017)
0.007 
(0.019)
0.019 
(0.021)
Married 0.108 
(0.040)
-0.123 
(0.119)
0.091 
(0.080)
0.063 
(0.100)
0.513 
(0.121)
0.271 
(0.124)
0.031 
(0.153)
Number of 
dependent 
children 
-0.034 
(0.020)
-0.032 
(0.089)
-0.032 
(0.030)
0.013 
(0.039)
0.094 
(0.258)
-0.099 
(0.449)
-
Country of birth -0.179 
(0.081)
-0.219 
(0.192)
-0.074 
(0.131)
-0.185 
(0.166)
-0.544 
(0.251)
0.172 
(0.378)
-0.502 
(0.626)
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Location parameters 
1 -2.577 
(0.099)
-2.272 
(0.376)
-2.940 
(0.291)
-2.030 
(0.451)
-1.205 
(1.062)
-2.178 
(1.344)
-0.714 
(1.697)
2 -1.787 
(0.089)
-1.377 
(0.332)
-2.314 
(0.277)
-1.211 
(0.443)
-0.175 
(1.056)
-1.296 
(1.339)
0.010 
(1.695)
3 -0.779 
(0.085)
-0.226 
(0.324)
-1.303 
(0.270)
-0.300 
(0.441)
0.861 
(1.056)
-0.021 
(1.337)
0.866 
(1.696)
4 0.632 
(0.085)
1.118 
(0.325)
0.198 
(0.268)
1.095 
(0.441)
2.281 
(1.058)
1.459 
(1.339)
2.331 
(1.699)
Number of 
observations 
4814 911 1448 1177 571 471 236 
- Loglikelihood 4376.5 622.3 1276.1 1095.5 548.3 483.0 276.0 
Pseudo R2 0.285 0.165 0.197 0.279 0.408 0.426 0.357 
1998 
Problems with 
arms, legs, etc. 
-0.676 
(0.039)
-0.744 
(0.136)
-0.782 
(0.078)
-0.739 
(0.073)
-0.726 
(0.105)
-0.387 
(0.103)
-0.644 
(0.135)
Difficulty in 
seeing 
-0.260 
(0.078)
0.088 
(0.262)
-0.167 
(0.193)
-0.604 
(0.165)
-0.078 
(0.240)
-0.363 
(0.186)
-0.161 
(0.175)
Difficulty in 
hearing 
-0.132 
(0.055)
-0.482 
(0.256)
-0.210 
(0.154)
-0.288 
(0.118)
-0.092 
(0.132)
-0.043 
(0.118)
-0.081 
(0.135)
Skin conditions, 
allergies 
0.044 
(0.052)
-0.206 
(0.125)
0.009 
(0.089)
0.164 
(0.113)
-0.048 
(0.167)
-0.016 
(0.168)
0.223 
(0.269)
Chest, breathing 
problems 
-0.663 
(0.047)
-0.301 
(0.120)
-0.758 
(0.093)
-0.711 
(0.110)
-0.827 
(0.131)
-0.658 
(0.122)
-0.839 
(0.156)
Heart, blood -0.692 
(0.050)
-1.114 
(0.486)
-0.937 
(0.161)
-0.670 
(0.101)
-0.751 
(0.106)
-0.667 
(0.103)
-0.524 
(0.138)
Stomach, liver, 
kidney 
-0.793 
(0.064)
-1.782 
(0.315)
-0.949 
(0.136)
-0.715 
(0.114)
-0.789 
(0.171)
-0.638 
(0.159)
-0.557 
(0.211)
Diabetes -0.492 
(0.095)
-0.713 
(0.444)
-0.816 
(0.260)
-0.549 
(0.215)
-0.517 
(0.227)
-0.252 
(0.180)
-0.548 
(0.253)
Nerves, anxiety, 
depression 
-0.812 
(0.074)
-1.353 
(0.249)
-0.759 
(0.137)
-1.063 
(0.145)
-0.575 
(0.195)
-0.669 
(0.231)
-0.243 
(0.288)
Alcohol, drugs -0.652 
(0.196)
-1.456 
(0.443)
-1.020 
(0.313)
-0.241 
(0.421)
0.295 
(0.665)
0.075 
(0.666)
-
Epilepsy -0.420 
(0.179)
-0.179 
(0.393)
-0.377 
(0.252)
0.006 
(0.645)
-0.242 
(0.549)
-1.073 
(1.111)
-
Migraine, chronic 
headaches 
-0.301 
(0.073)
-0.312 
(0.206)
-0.408 
(0.123)
-0.255 
(0.141)
-0.293 
(0.267)
-0.244 
(0.220)
0.511 
(0.380)
Other -0.946 
(0.077)
-0.497 
(0.254)
-1.226 
(0.190)
-1.072 
(0.154)
-0.911 
(0.192)
-0.733 
(0.185)
-0.818 
(0.222)
Other control variables 
Years of 
education 
0.017 
(0.006)
0.087 
(0.039)
-0.001 
(0.013)
0.017 
(0.011)
0.022 
(0.017)
0.021 
(0.019)
0.005 
(0.023)
Age 0.002 
(0.001)
0.032 
(0.014)
0.009 
(0.007)
0.026 
(0.008)
-0.006 
(0.016)
0.013 
(0.017)
0.031 
(0.017)
Married 0.079 
(0.038)
0.002 
(0.115)
0.083 
(0.076)
0.117 
(0.087)
0.064 
(0.129)
0.142 
(0.112)
-0.027 
(0.141)
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Number of 
dependent 
children 
-0.006 
(0.018)
-0.131 
(0.110)
-0.037 
(0.027)
0.039 
(0.036)
0.072 
(0.118)
-0.187 
(0.481)
-
Country of birth -0.238 
(0.633)
-0.023 
(1.100)
-0.130 
(0.786)
- - - -
Location parameters 
1 -2.815 
(0.102)
-1.859 
(0.541)
-3.141 
(0.288)
-1.621 
(0.426)
-3.380 
(0.987)
-1.733 
(1.215)
-0.446 
(1.385)
2 -1.830 
(0.091)
-0.519 
(0.494)
-1.985 
(0.259)
-0.652 
(0.418)
-2.371 
(0.980)
-0.949 
(1.212)
0.609 
(1.380)
3 -0.829 
(0.087)
0.509 
(0.491)
-0.934 
(0.254)
0.235 
(0.417)
-1.277 
(0.977)
0.221 
(1.211)
1.587 
(1.381)
4 0.663 
(0.087)
2.017 
(0.494)
0.584 
(0.253)
1.781 
(0.419)
0.227 
(0.976)
1.681 
(1.213)
3.086 
(1.389)
Number of 
observations 
5043 897 1543 1242 564 506 291 
- Loglikelihood 4654.1 -500.8 1350.7 1229.5 580.5 565.4 349.8 
Pseudo R2 0.327 0.178 0.283 0.367 0.412 0.338 0.333 
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Table 7 Parameter estimates health status women, 1991-1998 (standard errors 
in brackets) 
 All Age 
  25 25 - 40 40 - 55 55 - 65 65 - 75 75 > 
1991 
Health problems and disabilities 
Problems with 
arms, legs, etc. 
-0.681 
(0.038)
-0.545 
(0.137)
-0.843 
(0.093)
-0.686 
(0.073)
-0.666 
(0.093)
-0.744 
(0.094)
-0.480 
(0.112)
Difficulty in 
seeing 
-0.227 
(0.057)
-0.036 
(0.180)
-0.290 
(0.151)
-0.275 
(0.128)
-0.250 
(0.162)
-0.197 
(0.129)
-0.150 
(0.126)
Difficulty in 
hearing 
-0.197 
(0.062)
-0.439 
(0.234)
-0.389 
(0.194)
-0.321 
(0.157)
-0.133 
(0.161)
-0.019 
(0.128)
-0.135 
(0.123)
Skin conditions, 
allergies 
-0.114 
(0.046)
-0.094 
(0.097)
-0.120 
(0.077)
-0.050 
(0.102)
-0.086 
(0.158)
-0.245 
(0.192)
-0.248 
(0.206)
Chest, breathing 
problems 
-0.812 
(0.050)
-1.071 
(0.131)
-0.641 
(0.102)
-0.812 
(0.114)
-1.180 
(0.140)
-0.839 
(0.127)
-0.503 
(0.144)
Heart, blood -0.642 
(0.047)
-0.992 
(0.198)
-0.528 
(0.151)
-0.781 
(0.107)
-0.622 
(0.108)
-0.601 
(0.094)
-0.517 
(0.119)
Stomach, liver, 
kidney 
-0.789 
(0.064)
-0.833 
(0.198)
-0.925 
(0.135)
-0.951 
(0.132)
-0.678 
(0.170)
-0.430 
(0.170)
-0.802 
(0.181)
Diabetes -0.906 
(0.118)
-0.947 
(0.631)
-1.704 
(0.452)
-1.121 
(0.273)
-0.717 
(0.233)
-0.629 
(0.260)
-0.983 
(0.257)
Nerves, anxiety, 
depression 
-0.829 
(0.059)
-1.069 
(0.199)
-1.040 
(0.117)
-0.788 
(0.117)
-0.575 
(0.165)
-0.641 
(0.154)
-0.876 
(0.191)
Alcohol, drugs -0.642 
(0.262)
-0.940 
(0.779)
-0.562 
(0.348)
-0.321 
(0.770)
-1.404 
(0.773)
- -
Epilepsy -0.995 
(0.182)
-1.346 
(0.332)
-1.275 
(0.379)
-0.822 
(0.326)
-0.894 
(0.549)
-0.240 
(1.075)
-
Migraine, chronic 
headaches 
-0.299 
(0.048)
-0.421 
(0.117)
-0.202 
(0.084)
-0.267 
(0.091)
-0.654 
(0.144)
-0.206 
(0.182)
-0.265 
(0.313)
Other -0.843 
(0.060)
-0.831 
(0.188)
-0.994 
(0.136)
-0.848 
(0.113)
-0.662 
(0.167)
-0.897 
(0.153)
-0.699 
(0.180)
Health problems and disabilities 
Years of 
education 
0.036 
(0.006)
0.045 
(0.024)
0.016 
(0.009)
0.042 
(0.011)
0.050 
(0.018)
0.054 
(0.020)
0.036 
(0.024)
Age 0.003 
(0.001)
0.029 
(0.016)
0.017  
(0.007)
-0.006 
(0.008)
0.035 
(0.016)
-0.011 
(0.016)
0.010 
(0.014)
Married 0.002 
(0.032)
-0.165 
(0.091)
-0.002 
(0.070)
0.013 
(0.080)
0.060 
(0.098)
-0.095 
(0.090)
-0.188 
(0.136)
Number of 
dependent 
children 
-0.023 
(0.017)
-0.103 
(0.062)
-0.039 
(0.025)
-0.051 
(0.046)
0.168 
(0.797)
- -
Country of birth -0.043 
(0.079)
0.357 
(0.238)
0.153 
(0.119)
-0.481 
(0.164)
-0.703 
(0.255)
0.314 
(0.326)
0.882 
(0.543)
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Location parameters 
1 -2.623 
(0.099)
-2.705 
(0.396)
-2.543 
(0.276)
-3.180 
(0.441)
-0.486 
(0.985)
-3.353 
(1.152)
-1.638 
(1.113)
2 -1.722 
(0.091)
-1.338 
(0.344)
-1.471 
(0.255)
-2.092 
(0.430)
0.101 
(0.983)
-2.530 
(1.149)
-0.846 
(1.110)
3 -0.741 
(0.088)
-0.139 
(0.337)
-0.551 
(0.251)
-1.179 
(0.427)
1.251 
(0.983)
-1.520 
(1.146)
0.148 
(1.109)
4 0.720 
(0.088)
1.354 
(0.339)
0.908 
(0.252)
0.295 
(0.427)
2.851 
(0.986)
0.021 
(1.145)
1.515 
(1.111)
Number of 
observations 
5409 885 1558 1298 640 617 411 
- Loglikelihood 5323.1 708.5 1359.5 1131.4 621.3 664.6 472.9 
Pseudo R2 0.313 0.292 0.250 0.332 0.379 0.349 0.261 
1998 
Problems with 
arms, legs, etc. 
-0.620 
(0.035)
-0.563 
(0.131)
-0.589 
(0.073)
-0.810 
(0.069)
-0.692 
(0.093)
-0.386 
(0.096)
-0.606 
(0.104)
Difficulty in 
seeing 
-0.131 
(0.065)
-1.077 
(0.297)
-0.173 
(0.176)
-0.212 
(0.185)
-0.010 
(0.172)
-0.178 
(0.155)
0.144 
(0.117)
Difficulty in 
hearing 
-0.175 
(0.057)
-0.009 
(0.223)
-0.375 
(0.169)
-0.162 
(0.140)
-0.182 
(0.167)
-0.035 
(0.126)
-0.157 
(0.106)
Skin conditions, 
allergies 
-0.110 
(0.041)
-0.061 
(0.094)
-0.172 
(0.070)
0.060 
(0.087)
-0.123 
(0.145)
-0.123 
(0.147)
-0.416 
(0.164)
Chest, breathing 
problems 
-0.589 
(0.042)
-0.602 
(0.101)
-0.322 
(0.082)
-0.713 
(0.099)
-0.925 
(0.129)
-0.518 
(0.113)
-0.915 
(0.126)
Heart, blood -0.442 
(0.043)
-0.380 
(0.222)
-0.534 
(0.130)
-0.560 
(0.090)
-0.459 
(0.102)
-0.420 
(0.093)
-0.391 
(0.098)
Stomach, liver, 
kidney 
-0.622 
(0.052)
-1.352 
(0.179)
-0.893 
(0.112)
-0.485 
(0.115)
-0.361 
(0.136)
-0.589 
(0.131)
-0.430 
(0.136)
Diabetes -0.545 
(0.091)
-0.801 
(0.386)
-0.741 
(0.278)
-0.767 
(0.226)
-0.555 
(0.228)
-0.603 
(0.173)
-0.150 
(0.198)
Nerves, anxiety, 
depression 
-0.884 
(0.049)
-0.756 
(0.170)
-1.010 
(0.093)
-0.982 
(0.095)
-1.006 
(0.138)
-0.865 
(0.146)
-0.533 
(0.147)
Alcohol, drugs -0.928 
(0.267)
-1.178 
(0.500)
-1.733 
(0.855)
-0.805 
(0.416)
-0.411 
(1.112)
1.050 
(1.100)
-
Epilepsy -1.062 
(0.155)
-1.185 
(0.320)
-1.494 
(0.262)
-0.655 
(0.290)
-0.182 
(0.768)
-0.949 
(0.551)
-
Migraine, chronic 
headaches 
-0.210 
(0.043)
-0.243 
(0.107)
-0.270 
(0.076)
-0.198 
(0.083)
-0.044 
(0.143)
-0.109 
(0.154)
-0.333 
(0.213)
Other -0.809 
(0.057)
-1.231 
(0.203)
-0.966 
(0.114)
-0.726 
(0.114)
-0.727 
(0.157)
-0.681 
(0.152)
-0.726 
(0.149)
Other control variables 
Years of 
education 
0.029 
(0.006)
0.045 
(0.042)
0.027 
(0.012)
0.014 
(0.011)
0.056 
(0.022)
0.022 
(0.019)
0.051 
(0.021)
Age 0.001 
(0.001)
0.040 
(0.015)
0.001 
(0.007)
0.007 
(0.008)
-0.005 
(0.015)
-0.028 
(0.016)
-0.024 
(0.011)
Married -0.005 
(0.030)
-0.093 
(0.088)
0.067 
(0.063)
-0.145 
(0.073)
0.063 
(0.097)
-0.119 
(0.091)
-0.181 
(0.120)
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Number of 
dependent 
children 
-0.003 
(0.016)
-0.021 
(0.066)
-0.023 
(0.023)
0.053 
(0.043)
-0.254 
(0.561)
- -
Country of birth -0.176 
(0.448)
-0.318 
(0.786)
0.661 
(0.823)
-0.626 
(0.766)
- - -
Location parameters 
1 -2.738 
(0.099)
-2.104 
(0.546)
-2.795 
(0.265)
-2.827 
(0.419)
-3.034 
(0.985)
-4.776 
(1.180)
-4.250 
(0.932)
2 -1.801 
(0.092)
-0.835 
(0.525)
-1.795 
(0.251)
-1.857 
(0.411)
-2.088 
(0.979)
-3.849 
(1.175)
-3.422 
(0.928)
3 -0.766 
(0.090)
0.125 
(0.523)
-0.795 
(0.247)
-0.751 
(0.408)
-0.929 
(0.977)
-2.768 
(1.171)
-2.316 
(0.924)
4 0.800 
(0.090)
1.779 
(0.525)
0.765 
(0.247)
0.868 
(0.409)
0.707 
(0.976)
-1.147 
(1.168)
-0.905 
(0.920)
Number of 
observations 
5845 944 1742 1390 639 608 522 
- Loglikelihood 5807.0 659.3 1705.1 1382.4 648.6 654.9 606.3 
Pseudo R2 0.342 0.268 0.309 0.377 0.387 0.331 0.338 
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Table 8 QALY weights by age group, 1991-1998 
 All Age group 
25 or 
younger 
25 - 40 40 - 55 55 - 65 65 – 75 Older 
than 75 
Men 
1991 0.818 0.889 0.858 0.825 0.760 0.670 0.663 
1998 0.753 0.831 0.812 0.755 0.671 0.617 0.579 
Women 
1991 0.757 0.826 0.831 0.781 0.693 0.619 0.593 
1998 0.691 0.775 0.755 0.694 0.650 0.587 0.514 
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Table 9 Quality adjusted life expectancy in years by gender and age, 1991-1998 
 At birth At age 
20 30 50 60 70 80 
Men 
1991 60.6 43.5 39.3 19.1 12.3 7.4 4.2 
1998 57.0 40.9 37.0 18.0 11.8 7.1 3.9 
Women 
1991 60.1 41.8 40.1 26.5 13.8 8.6 4.9 
1998 55.4 40.3 36.9 19.1 13.0 7.9 4.3 
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